Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Tobacco use and cancer: an epidemiologic perspective for geneticists

Oncogene volume 21, pages 7307–7325 (2002)Cite this article

Abstract

Much of what is known about the deleterious effects of tobacco use on health was learned from epidemiologic studies over the last half century. These studies establish unequivocally that tobacco use, particularly manufactured cigarette smoking, causes most cancers of the lung, oropharynx, larynx, and esophagus in the USA, and approximately one-third of all cancers of the pancreas, kidney, urinary bladder and uterine cervix. More recent evidence also implicates smoking with cancers of the stomach, liver and colorectum. While over half of the estimated 440 000 smoking-attributable deaths that occur annually in the USA involve non-malignant cardiovascular and respiratory conditions, smoking-attributable cancers are more recognized and feared. Geneticists increasingly study tobacco use as a model for environmental carcinogenicity. Tobacco-exposed populations provide opportunities to characterize the somatic mutations that give rise to specific cancers and to identify the inherited genetic traits that confer susceptibility or resistance. Studies to identify the genetic determinants of addiction may be particularly important. Future research to identify other susceptibility factors, such as genes that modify carcinogen metabolism or DNA repair, will need to be substantially larger and to quantify lifetime tobacco exposure with more precision than have past studies in order to distinguish gradations in risk due to exposure from those caused by genetic susceptibility. This review considers: (a) the epidemiology of tobacco use; (b) cancers presently classified as smoking-attributable by the US Surgeon General; (c) the magnitude of the epidemic of cancers and other diseases caused by tobacco use; (d) selected issues in the epidemiology of lung cancer; and (e) the interface of genetics and epidemiology in understanding, preventing, and treating tobacco-attributable disease.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9
Figure 10

Similar content being viewed by others

References

  • Ahsan H, Neugut A, Gammon M . 1997 Cancer Epidemiol. Biomarkers Prev. 10: 779–782

  • Ambrosone C, Freudenheim J, Graham S, Marshall J, Vena J, Brasure J, Michalek A, Laughlin R, Nemoto T, Gillenwater K, Shield P . 1996 J. Am. Med. Assoc. 276: 1494–1501

  • Auerbach O, Garfinkel L . 1986 Digest. Dis. Sci. 31: 1014–1020

  • Auerbach O, Hammond C, Garfinkel L . 1979 N. Engl. J. Med. 300: 381–386

  • Auerbach O, Hammond E, Garfinkel L . 1970 Cancer 25: 92–104

  • Auerbach O, Stout A, Hammond E, Garfinkel L . 1961 N. Engl. J. Med. 265: 253–267

  • Auerbach O, Stout A, Hammond E, Garfinkel L . 1962 N. Engl. J. Med. 267: 119–125

  • Auerbach O, Stout A, Hammond E, Garfinkel L . 1964 Am. Rev. Resp. Dis. 90: 867–876

  • Auerbach O, Stout A, Hammond E, Garfinkel L . 1965 Arch. Environ. Health 11: 4–15

  • Baron J . 1996 Br. Med. Bull. 52: 58–73

  • Bartsch H, Nair U, Risch A, Rojas M, Wikman H, Alexandrov K . 2000 Cancer Epidemiol. Biomarkers Prev. 9: 3–28

  • Bennett W, Alavanja M, Blomeke B, Vahakangas K, Castren K, Welsh J, Bowman ED, Khan MA, Flieder DB, Harris CC . 1999 J. Natl. Cancer Inst. 91: 2009–2014

  • Benowitz N . 2001 Risks associated with smoking cigarettes with low machine-measured yields of tar and nicotine Smoking and Tobacco Control Monograph No. 13. NIH Pub. No. 02-5074 U.S. Department of Health and Human Services, National Cancer Institute: Bethesda, MD

    Google Scholar 

  • Benowitz N, Perez-Stable E, Herrera B, Jacob P . 2002 J. Natl. Cancer Inst. 94: 108–114

  • Bergen A, Caporaso N . 1999 J. Natl. Cancer Inst. 91: 1365–1375

  • Berkson J . 1955 Proceedings of the Staff Meetings of the Mayo Clinic 30: 319–348

  • Berkson J . 1958 J. Am. Stat. Assoc. 53: 28–38

  • Best E, Josie G, Walker C . 1961 Canad. J. Public Health 52: 99–106

  • Brockton N, Little J, Sharp L, Cotton S . 2000 Am. J. Epidemiol. 151: 846–861

  • Brownson R, Chang J, Davis J . 1992 Epidemiology 3: 61–64

  • Burns D, Lee L, Shen L, Gilpin E, Tolley H, Vaughn J, Shanks T . (eds) 1997 Cigarette smoking behavior in the United States National Institutes of Health: Bethesda, MD

    Google Scholar 

  • Califano J, Leong P, Koch W, Eisenberger C, Sidransky D, Westra W . 1999 Clin. Cancer Res. 5: 1862–1867

  • Califano J, van der Riet P, Westra W, Nawroz H, Clayman G, Piantadosi S, Corio R, Lee D, Greenberg B, Koch W, Sidransky D . 1996 Cancer Res. 56: 2488–2492

  • Califano J, Westra W, Meininger G, Corio R, Koch W, Sidransky D . 2000 Clin. Cancer Res. 6: 347–352

  • Cardon L, Bell J . 2001 Nature Reviews/Genetics 2: 91–99

  • Castelao J, Yuan J, Skipper P, Tannenbaum S, Gago-Dominguez M, Crowder J, Ross R, Yu M . 2001 J. Natl. Cancer Inst. 93: 538–545

  • CDC. 1997 MMWR 46: 1217–1220

  • CDC. 2002 MMWR 51: 300–303

  • Clemmesen J . 1965 Statistical studies in the Aetiology of Malignant Neoplasms. I. Review and Results. Copenhagen: Munksgaard

  • Cohn B, Wingard D, Cirillo P, Cohen R, Kaplan G . 1996 J. Natl. Cancer Inst. 88: 1867

  • Cooper E, Lamb F, Sanders E, Hirst E . 1932 J. Hygiene, London 32: 293–300

  • Corrao M, Guindon G, Cokkinides V, Sharma N . 2000a Bulletin of the World Health Organization 78: 884–890

  • Corrao M, Guindon G, Sharma N, Shokoohi D . 2000b Tobacco Control: Country Profiles American Cancer Society: Atlanta, GA

    Google Scholar 

  • Cosma G, Crofts F, Currie D, Wirgin I, Toniolo P, Garte S . 1993 Cancer Epidemiol. Biomarkers Prev. 2: 53–57

  • Crofts F, Cosma G, Currie D, Taioli E, Toniolo P, Garte S . 1993 Carcinogenesis 14: 1729–1731

  • Croninger A, Graham E, Wynder E . 1958 Cancer Res. 18: 1263–1271

  • Denissenko M, Pao A, Tang M-S, Pfeifer G . 1996 Science 274: 430–432

  • Djordjevic M, Stellman S, Zang E . 2000 J. Natl. Cancer Inst. 92: 106–111

  • Doll R . 1996 Br. Med. Bull. 52: 35–49

  • Doll R . 1998 Stat. Methods Med. Res. 7: 87–117

  • Doll R, Hill A . 1950 Br. Med. J. 2: 739–748

  • Doll R, Hill A . 1954 Br. Med. J. 1: 1451–1455

  • Doll R, Hill A . 1956 Br. Med. J. 2: 1071–1081

  • Doll R, Hill A . 1964 Br. Med. J. 1: 1399–1410

  • Doll R, Hill A, Kreyberg L . 1957 Br. J. Cancer ii: 43–48

  • Doll R, Peto R . 1978 J. Epidemiol. Community Health 32: 303–313

  • Doll R, Peto R . 1981 J. Natl. Cancer Inst. 66: 1191–1308

  • Dorn H . 1959 Public Health Rep. 74: 581–593

  • Eberhardt M, Ingram D, Makuc D et al . 2001 Urban and Rural Health Chartbook. Health, United States, 2001 National Center for Health Statistics: Hyattsville, Maryland

    Google Scholar 

  • Engelbreth-Holm J, Ahlmann J . 1957 Acta Pathalogical Microbiology Scandinavia 41: 267–272

  • Ford B . 1994 SmokeScreen – A guide to the personal risks and global effects of the cigarette habit North Perth, WA, Australia: Halcyon Press

    Google Scholar 

  • Fraumeni J, Mason T . 1974 J. Natl. Cancer Inst. 52: 659–665

  • Gaffney M, Altshuler B . 1988 J. Natl. Cancer Inst. 80: 925–931

  • Gammon M, Schoenberg J, Ahsan H, Risch H, Vaughan T, Chow W, Rotterdam H, West A, Dubrow R, Stanford J, Mayne S, Farrow D, Niwa S, Blot W, Fraumeni Jr J . 1997 J. Natl. Cancer Inst. 89: 1277–1284

  • Garcia-Closas M, Lubin J . 1999 Am. J. Epidemiol. 149: 689–692

  • Garte S . 2001 Cancer Epidemiol. Biomarkers Prev. 10: 1233–1237

  • Geisler S, Olshan A . 2001 Am. J. Epidemiol. 154: 95–105

  • Giovanucci E . 2001 Cancer Epidemiol. Biomarkers Prev. 10: 725–731

  • Glantz S, Slade J, Bero L, Hanauer P, Barnes D . 1996 The Cigarette Papers Glantz S, Slade J, Bero L, Hanauer P, Barnes D. (eds) Berkeley USA: University of California Press pp 1–24

    Google Scholar 

  • Green J, Banks E, Berrington A, Darby S, Deo H, Newton R . 2000 Br. J. Cancer 83: 412–417

  • Guerin M, Cuzin J . 1957 Bulletin of the Association of France Cancer 44: 387–408

  • Guo Z, Yamaguchi K, Sanchez-Cespedes M, Westra W, Koch W, Sidransky D . 2001 Clin. Cancer Res. 7: 1963–1968

  • Haenszel W, Shimkin M, Miller H . 1956 Public Health Monograph Number 45. PHS Pub. No. 463. Public Health Service U.S. Government Printing Office, 1956: Washington, D.C

    Google Scholar 

  • Hammond E . 1966 Natl. Cancer Inst. Monogr. 19: 127–204

  • Hammond E, Horn D . 1958 JAMA 166: 1294–1308

  • Harris J . 1983 J. Natl. Cancer Inst. 71: 473–479

  • Harris R, Zang E, Anderson J, Wynder E . 1993 Int. J. Epidemiol. 22: 592–599

  • Heath A, Cates R, Martin N, Meyer J, Hewitt J, Neale M et al . 1995 Behavior genetic approaches in behavioral medicine Turner J, Cardon L, Hewitt J. (eds) New York: Plenum Press pp 45–66

    Book  Google Scholar 

  • Hecht S . 1999 J. Natl. Cancer Inst. 91: 1194–1210

  • Hecht S . 2000 J. Natl. Cancer Inst. 92: 782–783

  • Henningfield J, Cohen C, Pickworth W . 1993 Nicotine Addiction, Principles and Management Orleans C, Slade J. (eds) New York: Oxford University Press pp 24–45

    Google Scholar 

  • Hickey K, Do K-A, Green A . 2001 Epidemiologic Reviews 23: 115–125

  • Hill A . 1965 Proc. Royal Soc. Med. 58: 295–300

  • Hopper J, Southey M, Dite G, Jolley D, Giles G, McCredie M, Easton D, Venter D, and Australian Breast Cancer Family Study . 1999 Cancer Epidemiol. Biomarkers Prev. 8: 741–747

  • Houlston R . 1999 Cancer Epidemiol. Biomarkers Prev. 8: 675–682

  • IARC. 1986 IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans: Tobacco Smoking International Agency for Reseach on Cancer: Lyon

  • IARC. 1987 IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans: Overall Evaluations of Carcinogenicity An Updating of IARC Monographs Volumes 1 to 42 International Agency for Reseach on Cancer: Lyon

  • Kahn H . 1966 Monograph 19, Epidemiological Study of Cancer and Other Chronic Diseases. Haenszel W. (ed.) U.S. Department of Health, Education, and Welfare, Public Health Service, National Cancer Institute: Bethesda, MD pp 1–126

    Google Scholar 

  • King T, Brunetta P . 1999 N. Engl. J. Med. 341: 1231–1233

  • Kreyberg L . 1962 Acta Pathol. Microbiol. Immunol. Scand. Suppl. 157: 11–92

  • Lagergren J, Bergstrom R, Lindgren A, Nyren O . 2000 Int. J. Cancer 85: 340–346

  • Lam T, Ho S, Hedley A, Mak K, Peto R . 2001 BMJ 323: 361–362

  • Landi M, Sinha R, Lanh N, Kadlubar F . 1999 Metabolic Polymorphisms and Susceptibility to Cancer Vol. 148: Vineas P, Malats N, Lang M, d'Errico A, Caporaso N, Cuzick J, Boffetta P (eds) Lyon, France: IARC pp 173–195

    Google Scholar 

  • Lang M, Pelkonen O . 1999 Metabolic Polymorphisms and Susceptilibity to Cancer Vol. 148: Vineis P, Malats N, Lang M, d'Errico A, Caporaso N, Cuzick J, Boffetta P. (eds) Lyon, France: IARC Scientific Publications, International Agency for Research on Cancer pp 13–22

    Google Scholar 

  • Law C, Day N, Chanmugaratnam K . 1976 Int. J. Cancer 17: 304–309

  • Lee J, Hong W, Hittelman W, Mao L, Lotan R, Shin D, Benner S, Xu X-C, Lee J, Papadimitrakopoulou V, Geyer C, Perez C, Martin J, El-Naggar A, Lippman S . 2000 Clin. Cancer Res. 6: 1702–1710

  • Leitch A . 1928 Fifth annual report of the British Empire Cancer Campaign London: British Empire Cancer Campaign pp 26

    Google Scholar 

  • Levin M, Goldstein H, Gerhardt P . 1950 J. Am. Med. Assoc. 143: 336–338

  • Liu BQ, Peto R, Chen ZM, Boreham J, Wu YP, Li JY, Campbell TC, Chen JS . 1998 BMJ 317: 1411–1422

  • London S, Idle J, Daly A, Coetzee G . 1999 Lancet 353: 898–899

  • Lubin J, Blot W . 1984 J. Natl. Cancer Inst. 73: 383–389

  • Mabry M, Nelkin B, Baylin S . 1998 The Genetic Basis of Human Cancer. Vogelstein B, Kinzler K. (eds) New York: McGraw-Hill pp 671–679

    Google Scholar 

  • Malone K, Daling J, Thompson J, O'Brien C, Francisco L, Ostrander E . 1998 JAMA 279: 922–929

  • Mao L, Lee J, Fan Y, Ro J, Batsakis J, Lippman S, Hittelman W, Hong W . 1996 Nat. Med. 2: 682–685

  • Martin G, Brown J, Eifler C, Houston G . 1999 J. Am. Dent. Assoc. 130: 945–954

  • Mattson M, Pollack E, Cullen J . 1987 Am. J. Public Health 77: 425–431

  • McDuffie H, Klassen D, Dossman J . 1991 J. Clin. Epidemiol. 44: 537–544

  • McGinnis J, Foege W . 1993 JAMA 270: 2207–2212

  • Mills C, Porter M . 1950 Cancer Res. 10: 539–542

  • Minna J, Roth J, Gazdar A . 2002 Cancer Cell 1: 49–52

  • Montesano R, Hainaut P, Hall J . 1997 Application of Biomarkers in Cancer Epidemiology Vol. 142: Toniolo P, Boffetta P, Shuker D, Rothman N, Hulka B, Pearce N. (eds) Lyon, France: IARC pp 291–301

    Google Scholar 

  • Moolgavkar S, Luebeck G . 1990 Risk Analysis 10: 323–341

  • Murray C, Lopez A . 1997 Lancet 349: 1498–1504

  • Newman B, Mu H, Butler L, Millikan R, Moorman P, King M . 1998 JAMA 279: 915–921

  • Niu S-R, Yang G-H, Chen Z-M, Wang J-L, Wang G-H, He X-Z et al . 1998 BMJ 317: 1423–1424

  • Novotny T, Warner K, Kendrick J, Remington P . 1988 Am. J. Public Health 78: 1187–1189

  • Osann K, Anton-Culver H, Kurosaki T, Taylor T . 1993 Int. J. Cancer 54: 44–48

  • Passey R . 1929 Sixth report of British Empire Cancer Research Campaign British Empire Cancer Campaign: London p 85

  • Perera F . 1996 J. Natl. Cancer Inst. 88: 496–509

  • Perez-Stable E, Herrera B, Jacob III P, Benowitz N . 1998 JAMA 280: 152–156

  • Perneger T . 2001 J. Natl. Cancer Inst. 93: 1600–1602

  • Peto R, Darby S, Deo H, Silcocks P, Whitley E, Doll R . 2000 Br. Med. J. 321: 323–329

  • Peto R, Lopez A, Boreham J, Thun M, Heath Jr C . 1992 Lancet 339: 1268–1278

  • Peto R, Lopez A, Boreham J, Thun M, Heath CJ . 1994 Mortality from smoking in developed countries 1950–2000 New York: Oxford University Press

    Google Scholar 

  • Peto R, Parish S, Gray R . 1985 Age-related factors in carcinogenesis Vol. 58: Likhachex A, Anisimov V, Montesano R. (eds) Lyon, France: IARC pp 43–53

    Google Scholar 

  • Pike M, Doll R . 1965 Lancet 1: 665–668

  • Prescott E, Osler M, Hein H, Borch-Johnsen K, Lange P, Schnohr P, Vestbo J . 1998 Epidemiology 79: 79–83

  • Ratnasinghe D, Yao S, Tangrea J, Qiao Y, Andersen M, Barrett M, Giffen C, Erozan Y, Tockman M, Taylor P . 2001 Cancer Epidemiol. Biomarkers Prev. 10: 119–123

  • Richie JJ, Carmella S, Muscat J, Scott D . 1997 Cancer Epidemiol. Biomarkers Prev. 6: 783–790

  • Ries L, Eisner M, Kosary C, Hankey B, Miller B, Clegg L, Edwards B . 2001 SEER Cancer Statistics Review, 1973–1998 Bethesda, MD: National Cancer Institute

    Google Scholar 

  • Risch H, Howe G, Jain M, Burch J, Holowaty E, Miller A . 1993 Am. J. Epidemiol. 138: 281–293

  • Roffo A . 1931 Zeitschrift fur Krebsforschung 33: 321–322

  • Rothman K, Greenland S . 1998 Modern Epidemiology. Philadelphia: Lippincott-Raven pp 7–28

    Google Scholar 

  • Ryberg D, Hewer A, Phillips D, Haugen A . 1994 Cancer Res. 54: 5801–5803

  • Schrek R, Baker L, Ballard G, Dolgoff S . 1950 Cancer Res. 10: 49–58

  • Shields P, Caporaso N, Falk R, Sugimura H, Trivers G, Trump B, Hoover R, Weston A, Harris C . 1993 Cancer Epidemiol. Biomarkers Prev. 2: 481–485

  • Shriver S, Bourdeau H, Gubish C, Tirpak D, Gaither Davis A, Luketich J, Siegfried J . 2000 J. Natl. Cancer Inst. 92: 24–33

  • Sidransky D . 1995 Monogr. Natl. Cancer Inst. 17: 27–29

  • Silverman S . 1998 Oral Cancer. Hamilton: B.C. Decker Inc pp 25–40

    Google Scholar 

  • Slade J . 1993 Nicotine Addiction, Principles and Management Orleans C, Slade J. (eds) New York: Oxford University Press pp 3–23

    Google Scholar 

  • Smith S, Fiore M . 1999 Primary Care 26: 433–461

  • Sommering S . 1795 De morbis vasorum absorbentium corporis humani Frankfurt: Varrentrapp & Wenner

    Google Scholar 

  • Spivack S, Fasco M, Walker V, Kaminsky L . 1997 Criti. Rev. Toxicol. 27: 319–365

  • Stellman S, Takezaki T, Wang L, Chen Y, Citron M, Djordjevic M, Harlap S, Muscat J, Neugut A, Wynder E, Oqawa H, Tajima K, Aoki K . 2001 Cancer Epidemiol. Biomarkers Prev. 10: 1193–1199

  • Stern M, Umbach D, van Gils C, Lunn R, Taylor J . 2001 Cancer Epidemiol. Biomarkers Prev. 10: 125–131

  • Stewart J . 2001 Cancer 91: 2476–2482

  • Strange R, Fryer A . 1999 Metabolic Polymorphisms and Suseptilibity to Cancer Vineis P, Malats N, Lang M, d'Errico A, Caporaso N, Cuzick J, Boffetta P. (eds) Lyon, France: IARC Scientific Publications No. 148. International Agency for Research on Cancer pp 231–249

    Google Scholar 

  • Straub R, Sullivan P, Ma Y, Myakishev M, Harris-Kerr C, Wormley B, Kadambi B, Sadek H, Silverman MA, Webb BT, Neale MC, Bulik CM, Joyce PR, Kandler KS . 1999 Mol. Psychiatry 4: 129–144

  • Strong L, Amos C . 1996 Cancer Epidemiology and Prevention Schottenfeld D, Fraumeni J. (eds) New York: Oxford University Press pp 559–583

    Google Scholar 

  • Struewing J, Hartge P, Wacholder S, Baker S, Berlin M, McAdams M, Timmerman M, Brody L, Tucker M . 1997 N. Engl. J. Med. 336: 1401–1408

  • Sugiura K . 1956 Gann. 47: 243–244

  • Taioli E, Ford J, Trachman J, Li Y . 1998 Carcinogenesis 19: 813–817

  • Thun M . 1998 Tobacco Control 7: 223–226

  • Thun M, Calle E, Rodriguez C, Wingo P . 2000 Cancer Epidemiol. Biomarkers Prev. 9: 861–868

  • Thun M, Day-Lally C, Meyers D, Calle E, Flanders W, Namboodiri M, Heath C . 1997a Monograph 8 In Changes in Cigarette-related Disease Risks and Their Implication for Prevention and Control Burns D, Garfinkel L, Samet J. (eds) Bethesda, MD: National Institutes of Health

    Google Scholar 

  • Thun M, Day-Lally C, Myers D, Calle E, Flanders W, Zhu B, Namboodiri M, Heath CJ . 1997b National Cancer Institute, Smoking and Tobacco Control, Monograph 8: Changes in Cigarette-Related Disease Risks and Their Implication for Prevention and Control. NIH Publication No. 97-4213 Washington, DC: National Institutes of Health pp. 305–382

    Google Scholar 

  • Thun M, Lally C, Flannery J, Calle E, Flanders W, Heath C . 1997c J. Natl. Cancer Inst. 89: 1580–1586

  • Tredaniel J, Boffetta P, Buiatti E, Saracci R, Hirsch A . 1997 Int. J. Cancer 72: 565–573

  • US Department of Agriculture. 2001 US Department of Agriculture, Commodity Economics Division Research Service: Washington, D.C

  • US Department of Health and Human Services. 1988 Reducing the Health Consequences of Smoking: 25 Years of Progress: A Report of the Surgeon General US Department of Health and Human Services, Public Health Service, Centers for Disease Control, Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health: Rockville, MD

  • US Department of Health and Human Services. 1989 The Health Benefits of Smoking Cessation: A Report of the Surgeon General US Department of Health and Human Services, Public Health Service, Centers for Disease Control, Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health: Rockville, MD

  • US Department of Health and Human Services. 1990 Nicotine Addiction. A Report of the Surgeon General DHHS Publication No. (CDC) 88-8406: Rockville, MD

  • US Public Health Service. 1964 Smoking and Health: Report of the Advisory Committee to the Surgeon General of the Public Health Service US Department of Health, Education, and Welfare, Public Health Service, Center for Disease Control: Washington, DC

  • Wakai K, Seki N, Tamakoshi A, Kondo T, Nishino Y, Ito Y, Suzuki K, Ozasa K, Watanabe Y, Ohno Y and et al . 2001 Jpn. J. Cancer Res. 92: 821–828

  • Weinberg C, Sandler D . 1999 J. Natl. Cancer Inst. 91: 1985–1986

  • Westra W, Sidransky D . 1998 J. Natl. Cancer Inst. 90: 1500–1501

  • Wu-Williams A, Samet J . 1994 Epidemiology of Lung Cancer Samet J (ed.) New York: Marcel Dekker, Inc pp 71–108

    Google Scholar 

  • Wynder E, Graham E . 1950 J. Am. Med. Assoc. 143: 329–336

  • Wynder E, Graham E, Croninger A . 1953 Cancer Res. 13: 855–864

  • Wynder E, Graham E, Croninger A . 1955 Cancer Res. 15: 445–448

  • Yuan J-M, Ross R, Wang X-L, Gao Y-T, Henderson B, Yu M . 1996 JAMA 275: 1646–1650

  • Zang E, Wynder E . 1992 Cancer 70: 69–76

  • Zang E, Wynder E . 1996 J. Natl. Cancer Inst. 88: 183–192

Download references

Author information

Authors and Affiliations

  1. Department of Epidemiology and Surveillance Research, American Cancer Society, 1599 Clifton Road, Atlanta, 30329-4251, Georgia, GA, USA

    Michael J Thun, S Jane Henley & Eugenia E Calle

Authors
  1. Michael J Thun
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S Jane Henley
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Eugenia E Calle
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael J Thun.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Thun, M., Henley, S. & Calle, E. Tobacco use and cancer: an epidemiologic perspective for geneticists. Oncogene 21, 7307–7325 (2002). https://doi.org/10.1038/sj.onc.1205807

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1205807

Keywords

This article is cited by

Search

Advanced search

Quick links